Prediction of Acute Pancreatitis Outcome
Launched by ASSIUT UNIVERSITY · Oct 21, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving how we predict the outcomes of patients with acute pancreatitis, a sudden inflammation of the pancreas that can cause severe abdominal pain. The researchers are trying to find ways to make these predictions using simple and low-cost laboratory tests. The goal is to help doctors better understand how patients with this condition will progress and recover.
To be eligible for the trial, participants need to be over 18 years old and have specific signs of acute pancreatitis, such as high levels of a certain enzyme in their blood and typical abdominal pain. However, people with liver diseases, kidney diseases, or cancer will not be included in this study. If you choose to participate, you can expect to undergo some routine tests and monitoring to help researchers gather important information. This is an exciting opportunity to contribute to better care for patients with acute pancreatitis!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients age \>18 years old Serum amylase \>3 times the upper limit of normal. abdominal pain consistent with acute pancreatitis. Typical abdominal ultrasonography and tomography findings in the routine imaging of the patients were accepted as acute pancreatitis.
- • Patient complaint of abdominal pain -
- Exclusion Criteria:
- • liver diseases patients renal diseases patients malignancy patients
- • -
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported